What Causes Ms In Females Hormones Genes More? Root Causes

Multiple sclerosis is not caused by a single factor. It develops when a person inherits a genetic susceptibility, and then something in their environment — most likely a viral infection — triggers the immune system to attack the protective coating around nerve fibers. Women are roughly two to three times more likely to develop MS than men, and researchers believe this difference involves hormones, genetics, and how the immune system itself differs between sexes. No one gene causes MS. No one hormone causes MS. It is the interaction that matters.

What Causes MS in Females — Hormones, Genes, or Something Else?

All three contribute, but they contribute differently. Genes set the level of risk. Hormones influence how that risk plays out. And neither would likely be enough on its own without an environmental trigger.

The strongest genetic signal in MS sits in a region of chromosome 6 called the HLA complex. This region helps the immune system tell the difference between the body’s own cells and foreign invaders. A particular version of a gene called HLA-DRB1*15:01 is the most well-established genetic risk factor for MS. But carrying it does not mean you will get MS. Many people carry it and never develop the disease.

In fact, the largest genetic studies in MS — including work published in the journal Nature Genetics — have identified over 200 genetic variants associated with the disease. Each one adds only a tiny amount of risk. The HLA variant contributes the most, but even it accounts for only a fraction of overall risk. This tells us genetics loads the gun. Something else pulls the trigger.

Hormones are part of that “something else.” The female predominance in MS is not subtle — it is one of the most consistent findings across populations worldwide. And the pattern shifts with hormonal life stages, which gives researchers important clues.

Why Are Women More Likely to Get MS Than Men?

The female-to-male ratio in MS is roughly 2:1 to 3:1, and it has been increasing over the past several decades. That increase is too fast to be explained by genetics alone. Something about modern environments or hormonal exposures is changing.

Sex hormones influence the immune system directly. Estrogen, progesterone, and testosterone all have receptors on immune cells. They can shift the balance between inflammatory and regulatory immune activity. In general, estrogen tends to enhance certain immune responses, which may help explain why women mount stronger immune reactions to infections and vaccines — but also why they have higher rates of autoimmune diseases overall. MS is not unique in this regard. Lupus, rheumatoid arthritis, and thyroid autoimmune conditions all show female predominance.

But hormones alone do not explain the full picture. Research has increasingly focused on the X chromosome. Women have two X chromosomes; men have one. Some genes on the X chromosome are involved in immune regulation. Having two copies — or the way those genes are expressed — may contribute to autoimmune risk. This area is still being actively studied, and the evidence is not yet conclusive. What is clear is that the sex difference in MS is real, consistent, and not explained by any single mechanism.

How Do Hormonal Life Stages Affect MS?

MS symptoms often change around major hormonal transitions. These patterns have been observed in clinical practice for decades and are supported by a growing body of research, though the mechanisms are not fully understood.

During pregnancy, especially in the second and third trimesters, many women with MS experience fewer relapses. Research published in journals such as Neurology has documented this reduction consistently. The likely explanation involves a shift in immune activity that helps the body tolerate the fetus — a shift that also dampens MS-related inflammation. After delivery, relapse rates often rise in the first few months before returning to baseline. This postpartum increase is well-documented but temporary.

Puberty is another transition point. MS rarely appears before puberty, and the female predominance becomes more pronounced after puberty begins. This timing suggests that sex hormones play a role in when the disease first manifests, though they are not the sole driver.

Menopause is less well-studied. Some women report changes in symptoms during perimenopause and after menopause, but the evidence here is mixed. Some studies suggest a slight worsening of disability progression after menopause; others do not confirm this. The hormonal changes of menopause are complex — estrogen, progesterone, and other hormones all decline at different rates — and isolating the effect on MS is difficult. No clinical guidelines currently recommend hormone replacement therapy specifically for MS management.

What Role Do Genes Play in MS Risk?

Genetics contribute significantly to MS risk, but not in a simple way. MS is not inherited in the pattern of a single-gene disorder like cystic fibrosis or Huntington’s disease. Instead, it is polygenic — meaning many genes, each with a small effect, combine to influence risk.

The HLA region on chromosome 6 is the most important genetic contributor. Beyond HLA, the 200-plus variants identified through large-scale genetic studies are mostly in or near genes involved in immune function. This reinforces the central role of the immune system in MS.

Family studies show that having a first-degree relative with MS increases risk, but the absolute risk remains low. Most people with a family history never develop MS. And most people with MS have no family history at all. This tells us that genetics alone is not enough.

Interestingly, identical twins — who share all their genes — do not both develop MS most of the time. When one identical twin has MS, the other has a higher risk than the general population but still usually does not develop the disease. This is strong evidence that environmental factors are essential.

What Environmental Factors Trigger MS?

The strongest environmental candidate is Epstein-Barr virus (EBV), a common virus that infects most people at some point in their lives. A large study published in the journal Science in 2022 found that EBV infection substantially increased the risk of developing MS. The study followed millions of US military personnel over decades and showed that nearly all who developed MS had been infected with EBV before their diagnosis.

That finding was significant, but it does not mean EBV causes MS in everyone who gets it. Most people are infected with EBV — many as children or young adults — and the vast majority never develop MS. So EBV appears to be necessary but not sufficient. Other factors must be involved.

Other environmental factors associated with MS risk include:

• Low vitamin D levels — MS is more common at higher latitudes, where sunlight exposure and vitamin D production are lower. Whether low vitamin D is a cause or a consequence of MS is still debated, and clinical trials of vitamin D supplementation for MS prevention have not shown clear benefit.
• Smoking — Cigarette smoking is associated with an increased risk of MS and may worsen disease progression. This association is well-established.
• Childhood obesity — Some studies suggest that obesity during childhood or adolescence may increase MS risk, particularly in girls. The evidence is growing but not definitive.
• Gut microbiome — Research into the gut bacteria of people with MS is ongoing. Some differences have been observed, but no specific bacterial profile has been confirmed as a cause.

None of these factors, alone or together, fully explains why one person develops MS and another does not. The current understanding is that MS results from a combination of genetic susceptibility, immune system dysfunction, viral exposure, and environmental influences — all converging at a particular time in a particular person.

Is MS Caused by Hormonal Imbalance?

No. MS is not caused by a hormonal imbalance in the way that thyroid disease or diabetes involves hormonal dysfunction. The hormonal influence on MS is more about how sex hormones modulate immune activity and interact with genetic risk — not about having too much or too little of a specific hormone.

This distinction matters because some people promote hormone-balancing treatments as a way to manage or prevent MS. No clinical evidence supports those claims. Hormone therapy is not a treatment for MS. The treatments that have been shown to reduce relapses and slow progression are immunomodulatory drugs — not hormones.

That said, research into the hormonal aspects of MS is active and legitimate. Scientists are studying whether estrogen or other hormones could be used therapeutically in specific contexts, such as protecting against postpartum relapses. Some early trials have explored this, but results are not yet strong enough to support routine use. This is an area of ongoing investigation, not established treatment.

Can You Prevent MS If You Have Risk Factors?

There is currently no proven way to prevent MS, even in people with known genetic risk or a family history. This is an honest and important limitation.

Researchers are exploring prevention strategies — including targeting EBV with vaccines or antiviral treatments, and studying whether early intervention in people with early signs of MS (such as radiologically isolated syndrome) can delay or prevent the disease. Some studies suggest that early treatment in these cases may delay a first clinical event, but this is still an evolving area.

What is clear is that having a genetic risk factor like HLA-DRB1*15:01 does not mean you will develop MS. Most people with that variant never do. And most people with MS have no known family history. The interplay between genes, hormones, and environment is complex, and no single factor determines the outcome.